MA27631A1 - Procede de culture cellulaire n'utilisant pas de composants d'origine animale - Google Patents
Procede de culture cellulaire n'utilisant pas de composants d'origine animaleInfo
- Publication number
- MA27631A1 MA27631A1 MA28488A MA28488A MA27631A1 MA 27631 A1 MA27631 A1 MA 27631A1 MA 28488 A MA28488 A MA 28488A MA 28488 A MA28488 A MA 28488A MA 27631 A1 MA27631 A1 MA 27631A1
- Authority
- MA
- Morocco
- Prior art keywords
- cell culture
- cells
- animal
- relates
- animal origin
- Prior art date
Links
- 241001465754 Metazoa Species 0.000 title abstract 5
- 238000004113 cell culture Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 abstract 3
- 210000004102 animal cell Anatomy 0.000 abstract 2
- 230000001419 dependent effect Effects 0.000 abstract 2
- 210000001840 diploid cell Anatomy 0.000 abstract 2
- 239000002609 medium Substances 0.000 abstract 2
- 102000004142 Trypsin Human genes 0.000 abstract 1
- 108090000631 Trypsin Proteins 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 239000006143 cell culture medium Substances 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 239000003102 growth factor Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000012588 trypsin Substances 0.000 abstract 1
- 229960004854 viral vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/105—Insulin-like growth factors [IGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
- C12N2770/32451—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
PROCÉDÉ DE CULTURE CELLULAIRE N'UTILISANT PAS DE COMPOSANTS D'ORIGINE ANIMALE La présente invention concerne un procédé de culture de cellules animales, de préférence des cellules diploïdes humaines ancrage-dépendantes, en absence de composants exogènes d'origine animale primaire, et un milieu de culture cellulaire essentiellement exempt de composants exogènes d'origine animale primaire approprié pour réaliser ledit procédé. En particulier, l'invention concerne un milieu de culture cellulaire qui comprend au moins un, et de manières davantage préférées plusieurs facteurs de croissance exogènes n'ayant pas une origine animale. La présente invention concerne également un procédé destiné à la culture de cellules animales, de préférence des cellules diploïdes humaines ancrage-dépendantes, dans un milieu selon l'invention, impliquant l'utilisation d'un substitut de trypsine d'origine non-animale pour le repiquage des cellules. L'invention concerne en outre un procédé de production de virus, de vaccins viraux et équivalent. (Figure 1)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0304799.0A GB0304799D0 (en) | 2003-03-03 | 2003-03-03 | Novel method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA27631A1 true MA27631A1 (fr) | 2005-11-01 |
Family
ID=9953995
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA28488A MA27631A1 (fr) | 2003-03-03 | 2005-09-09 | Procede de culture cellulaire n'utilisant pas de composants d'origine animale |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US8034617B2 (fr) |
| EP (3) | EP2186885A1 (fr) |
| JP (2) | JP4787739B2 (fr) |
| KR (1) | KR101242090B1 (fr) |
| CN (2) | CN101200705A (fr) |
| AU (1) | AU2004217807B2 (fr) |
| BR (1) | BRPI0407636A (fr) |
| CA (1) | CA2517327A1 (fr) |
| CO (1) | CO5601047A2 (fr) |
| GB (1) | GB0304799D0 (fr) |
| IS (1) | IS7992A (fr) |
| MA (1) | MA27631A1 (fr) |
| MX (1) | MXPA05009096A (fr) |
| NO (1) | NO20054124L (fr) |
| NZ (1) | NZ541908A (fr) |
| RU (1) | RU2369634C2 (fr) |
| WO (1) | WO2004078955A1 (fr) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2335650B1 (fr) | 2003-12-11 | 2012-10-03 | Isto Technologies Inc. | Système chondral particulier |
| JP4650798B2 (ja) * | 2004-04-19 | 2011-03-16 | デンカ生研株式会社 | ウイルスの生産方法 |
| EP1812557A4 (fr) * | 2004-10-29 | 2009-11-04 | Centocor Ortho Biotech Inc | Compositions de milieux chimiquement definis |
| WO2006095431A1 (fr) * | 2005-03-10 | 2006-09-14 | Kyoritsu Seiyaku Corporation | Lignee cellulaire cultivable sans composant derive d’un animal, procede destine a l’etablir, procede de production de virus utilisant la lignee cellulaire et procede de production de vaccins |
| EP1891207A2 (fr) * | 2005-06-03 | 2008-02-27 | Biovitrum AB | Procede de culture de cellules animales comprenant l'apport de peptones derives de plantes |
| JP5292533B2 (ja) | 2005-08-26 | 2013-09-18 | ジンマー・インコーポレイテッド | インプラントおよび関節疾患の治療、置換および治療方法 |
| EP1764117A1 (fr) | 2005-09-20 | 2007-03-21 | Zimmer GmbH | Implant pour la réparation de défauts cartilagineux et son procédé de préparation |
| US8163549B2 (en) | 2006-12-20 | 2012-04-24 | Zimmer Orthobiologics, Inc. | Method of obtaining viable small tissue particles and use for tissue repair |
| EP2134297B1 (fr) | 2007-04-12 | 2017-03-08 | Zimmer, Inc. | Dispositif de réparation de tissu |
| FI20075417A0 (fi) * | 2007-06-05 | 2007-06-05 | Marjo-Riitta Suuronen | Koostumuksia ja menetelmiä alkion kantasolujen kasvatukseen |
| DK2250251T3 (en) | 2008-01-09 | 2018-01-22 | Sartorius Stedim Cellca Gmbh | Improved culture medium additive and method of using it |
| NZ700477A (en) | 2009-02-17 | 2016-04-29 | Glaxosmithkline Biolog Sa | Inactivated dengue virus vaccine with aluminium-free adjuvant |
| AU2011246503B2 (en) | 2010-04-26 | 2013-09-26 | Novartis Ag | Improved cell culture medium |
| CN101831415B (zh) * | 2010-05-12 | 2012-05-30 | 江苏博立生物制品有限公司 | 一种提高糖化酶发酵水平的方法 |
| EP2681306B1 (fr) * | 2011-02-28 | 2019-01-09 | President and Fellows of Harvard College | Système de culture cellulaire |
| WO2013084190A1 (fr) | 2011-12-08 | 2013-06-13 | Yeda Research And Development Co. Ltd. | Cellules pulmonaires fœtales de mammifères et leur utilisation thérapeutique |
| US9493744B2 (en) * | 2012-06-20 | 2016-11-15 | Genentech, Inc. | Methods for viral inactivation and other adventitious agents |
| US20130281355A1 (en) * | 2012-04-24 | 2013-10-24 | Genentech, Inc. | Cell culture compositions and methods for polypeptide production |
| JP6041199B2 (ja) * | 2012-09-14 | 2016-12-07 | 国立大学法人大阪大学 | 三次元細胞培養体の製造方法 |
| US20140178343A1 (en) | 2012-12-21 | 2014-06-26 | Jian Q. Yao | Supports and methods for promoting integration of cartilage tissue explants |
| ES3063334T3 (en) | 2015-06-18 | 2026-04-16 | Yeda Res & Dev | Conditioning protocols and use of same for tissue regeneration |
| US10004795B2 (en) * | 2015-09-08 | 2018-06-26 | Fundacao Butantan | Process for preparing an attenuated tetravalent dengue vaccine |
| BE1024160B9 (fr) | 2015-12-22 | 2017-12-06 | Glaxosmithkline Biologicals Sa | Formulation immunogène |
| CN105567628B (zh) * | 2016-01-30 | 2019-07-12 | 令世鑫 | 一种全悬浮培养mdck细胞的低血清培养基 |
| CN105695393B (zh) * | 2016-03-24 | 2019-09-10 | 友康恒业生物科技(北京)有限公司 | 一种mdck细胞无血清培养基及其用途和制备 |
| CN105779376B (zh) * | 2016-03-24 | 2019-08-30 | 友康恒业生物科技(北京)有限公司 | 一种流感病毒分离无血清培养基及其用途和制备 |
| KR101925079B1 (ko) * | 2017-05-24 | 2018-12-04 | 가천대학교 산학협력단 | Dna 정제-증폭을 위한 통합형 마이크로 디바이스 및 이를 이용한 dna 정제-증폭 방법 |
| CN107432931B (zh) * | 2017-08-03 | 2018-04-13 | 长春祈健生物制品有限公司 | 一种微载体培养水痘病毒制备疫苗的方法 |
| MX2021006115A (es) * | 2019-01-17 | 2021-07-07 | Boehringer Ingelheim Animal Health Usa Inc | Medio libre de suero para produccion de vacuna aviar y usos del mismo. |
| MX2022008144A (es) | 2019-12-31 | 2022-08-17 | Air Protein Inc | Composiciones alimenticias con alto contenido de proteinas. |
| WO2021151025A1 (fr) * | 2020-01-24 | 2021-07-29 | Air Protein, Inc. | Hydrolysats de protéines dérivés de micro-organisme, ainsi que leurs méthodes de préparation et d'utilisation |
| MX2022010931A (es) | 2020-03-02 | 2022-09-29 | Air Protein Inc | Composiciones estructuradas analogas a la carne con alto contenido de proteinas. |
| CN113373107B (zh) * | 2021-01-29 | 2022-12-30 | 上海生物制品研究所有限责任公司 | 一种大规模制备传代鸡胚细胞生产病毒的方法 |
| WO2024039216A1 (fr) * | 2022-08-19 | 2024-02-22 | 셀미트주식회사 | Procédé de culture de cellules animales ou d'une lignée de cellules animales |
| CN115627255B (zh) * | 2022-12-01 | 2023-04-07 | 天信和(苏州)生物科技有限公司 | 一种采用低血清培养基培养人二倍体细胞的方法 |
| KR102926380B1 (ko) * | 2025-02-19 | 2026-02-12 | (주)엑셀세라퓨틱스 | 줄기세포 유래 엑소좀의 제조방법, 엑소좀 및 이를 포함하는 조성물 |
| CN119979445B (zh) * | 2025-04-10 | 2025-09-09 | 四川大学 | 一种培养基、口腔黏膜上皮细胞模型,及其制备方法和用途 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2018228C (fr) | 1989-06-05 | 1996-02-27 | Nancy L. Parenteau | Systemes et milieu de culture cellulaire |
| GB9022545D0 (en) | 1990-10-17 | 1990-11-28 | Wellcome Found | Culture medium |
| DE4115722A1 (de) | 1991-05-14 | 1992-11-19 | Boehringer Mannheim Gmbh | Serumfreies medium zur kultivierung von saeugerzellen |
| RU2057176C1 (ru) * | 1992-05-20 | 1996-03-27 | Институт генетики АН Республики Молдова | Питательная среда для культивирования клеток человека и животных |
| DZ1706A1 (fr) * | 1992-08-07 | 2002-02-17 | Merck & Co Inc | Vaccin contre le virus de l'hepatite a. |
| US6180110B1 (en) | 1992-09-18 | 2001-01-30 | The United States Of America As Represented By The Department Of Health And Human Services | Attenuated hepatitis a virus vaccine which grows in MRC-5 cells |
| CN1088984A (zh) * | 1993-11-11 | 1994-07-06 | 江西省医学科学研究所 | 一种用于造血祖细胞培养的无血清培养基 |
| HRP950097A2 (en) | 1994-03-08 | 1997-06-30 | Merck & Co Inc | Hepatitis a virus culture process |
| ATE542891T1 (de) | 1994-11-10 | 2012-02-15 | Baxter Healthcare Sa | Verfahren zur herstellung von biologischen produkten in protein-freier kultur |
| WO1998000521A1 (fr) * | 1996-06-28 | 1998-01-08 | The Green Cross Corporation | Milieux exempts de serum, methode de culture de cellules d'origine animale, et procede de production de substances physiologiquement actives |
| WO1998004680A1 (fr) * | 1996-07-26 | 1998-02-05 | University Of Manitoba | Milieu ne contenant pas de serum, destine a la culture de cellules mammaliennes dependantes d'un support |
| US6103529A (en) * | 1996-10-10 | 2000-08-15 | Life Technologies, Inc. | Animal cell culture media comprising peptides derived from rice |
| AU7984498A (en) * | 1997-06-25 | 1999-01-04 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Serum-free cell growth medium |
| US6656719B1 (en) * | 1997-10-27 | 2003-12-02 | Merck & Co., Inc. | Serum-free, low-protein media for rotavirus vaccine production |
| FR2775983B1 (fr) | 1998-03-13 | 2000-11-10 | Pasteur Merieux Serums Vacc | Milieu et procede de propagation et de multiplication virales |
| WO1999057246A1 (fr) * | 1998-05-01 | 1999-11-11 | Life Technologies, Inc. | Milieux de culture de cellules animales comprenant des elements nutritifs derives des vegetaux |
| US6406909B1 (en) * | 1998-07-10 | 2002-06-18 | Chugai Seiyaku Kabushiki Kaisha | Serum-free medium for culturing animal cells |
| US6623959B2 (en) * | 2001-06-13 | 2003-09-23 | Ethicon, Inc. | Devices and methods for cell harvesting |
-
2003
- 2003-03-03 GB GBGB0304799.0A patent/GB0304799D0/en not_active Ceased
-
2004
- 2004-03-01 CA CA002517327A patent/CA2517327A1/fr not_active Abandoned
- 2004-03-01 RU RU2005125606/13A patent/RU2369634C2/ru not_active IP Right Cessation
- 2004-03-01 US US10/547,804 patent/US8034617B2/en not_active Expired - Fee Related
- 2004-03-01 EP EP10151350A patent/EP2186885A1/fr not_active Withdrawn
- 2004-03-01 BR BRPI0407636-2A patent/BRPI0407636A/pt not_active IP Right Cessation
- 2004-03-01 KR KR1020057016385A patent/KR101242090B1/ko not_active Expired - Fee Related
- 2004-03-01 NZ NZ541908A patent/NZ541908A/en unknown
- 2004-03-01 AU AU2004217807A patent/AU2004217807B2/en not_active Ceased
- 2004-03-01 EP EP04715891A patent/EP1599580A1/fr not_active Ceased
- 2004-03-01 EP EP10151351A patent/EP2192175A1/fr not_active Ceased
- 2004-03-01 MX MXPA05009096A patent/MXPA05009096A/es active IP Right Grant
- 2004-03-01 WO PCT/EP2004/002067 patent/WO2004078955A1/fr not_active Ceased
- 2004-03-01 JP JP2006504501A patent/JP4787739B2/ja not_active Expired - Fee Related
- 2004-03-01 CN CNA2007101866779A patent/CN101200705A/zh active Pending
- 2004-03-01 CN CN2004800058488A patent/CN1756837B/zh not_active Expired - Fee Related
-
2005
- 2005-08-18 IS IS7992A patent/IS7992A/is unknown
- 2005-08-31 CO CO05087280A patent/CO5601047A2/es not_active Application Discontinuation
- 2005-09-05 NO NO20054124A patent/NO20054124L/no not_active Application Discontinuation
- 2005-09-09 MA MA28488A patent/MA27631A1/fr unknown
-
2010
- 2010-07-12 JP JP2010157682A patent/JP2010273683A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20050105509A (ko) | 2005-11-04 |
| NO20054124D0 (no) | 2005-09-05 |
| MXPA05009096A (es) | 2005-10-19 |
| JP2010273683A (ja) | 2010-12-09 |
| BRPI0407636A (pt) | 2006-02-21 |
| AU2004217807B2 (en) | 2009-06-25 |
| US8034617B2 (en) | 2011-10-11 |
| RU2005125606A (ru) | 2006-03-10 |
| CN1756837A (zh) | 2006-04-05 |
| CO5601047A2 (es) | 2006-01-31 |
| GB0304799D0 (en) | 2003-04-09 |
| NO20054124L (no) | 2005-09-27 |
| JP4787739B2 (ja) | 2011-10-05 |
| KR101242090B1 (ko) | 2013-03-08 |
| EP2192175A1 (fr) | 2010-06-02 |
| CN1756837B (zh) | 2010-05-26 |
| RU2369634C2 (ru) | 2009-10-10 |
| AU2004217807A1 (en) | 2004-09-16 |
| US20060183224A1 (en) | 2006-08-17 |
| EP1599580A1 (fr) | 2005-11-30 |
| JP2006519023A (ja) | 2006-08-24 |
| CA2517327A1 (fr) | 2004-09-16 |
| WO2004078955A1 (fr) | 2004-09-16 |
| NZ541908A (en) | 2008-04-30 |
| IS7992A (is) | 2005-08-18 |
| EP2186885A1 (fr) | 2010-05-19 |
| CN101200705A (zh) | 2008-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA05009096A (es) | Metodo de cultivo celular libre de animal. | |
| DK0904351T3 (da) | Dyreceller og fremgangsmåder til replikationen af influenzavirus | |
| EP0954563A4 (fr) | Milieux de culture de cellules animales comprenant des substances nutritives derivees de plantes | |
| GB2432846B (en) | Medium and culture of embryonic stem cells | |
| WO2007115337A8 (fr) | Ingéniérie tissulaire utilisant des cellules souches embryonnaires humaines | |
| WO1999057246A8 (fr) | Milieux de culture de cellules animales comprenant des elements nutritifs derives des vegetaux | |
| BR0313559A (pt) | Método para o cultivo de células primárias e para a amplificação de vìrus sob condições isentas de soro | |
| IS6373A (is) | Mannafósturfrumur, sérhæfðar í blóðmyndandi frumur | |
| DK0910239T3 (da) | Transformation af bomuldplanter | |
| RU2012130928A (ru) | Способ культивирования адгезионных клеток | |
| DK1201749T3 (da) | Fremgangsmåde til fremstilling af humane bruskimplantater ved hjælp af in vitro dyrkede chondrocytter | |
| PL374782A1 (en) | Animal protein free media for cultivation of cells | |
| DK1170376T3 (da) | Fremgangsmåde til fremstilling af L-aminosyre eller nukleinsyre ved anvendelse af mikroorganisme | |
| DE122007000061I2 (de) | In vitro-rekonstitution von segmentierten negativstrang-rna-viren. | |
| CA2437962A1 (fr) | Methode d'extraction d'un virus a partir d'une culture cellulaire | |
| DE69626022D1 (de) | Verfahren zur industriellen herstellung eines japanischen enkephalitis impfstoffes, und so erhaltener impfstoff | |
| DE60334025D1 (de) | Verfahren zur herstellung von zellkulturen aus biologischen präparaten für chemotherapeutische und andere assays | |
| TW200636068A (en) | A method of culturing a cell and use of the same | |
| MX2025006558A (es) | Tratamiento con insulina para mejorar la genomanipulacion de linfocitos t | |
| DE69929174D1 (de) | Vermehrte und genetisch modifizierte populationen menschlicher hämatopoitischer stammzellen | |
| ATE258594T1 (de) | Verfahren zur steigerung des wachstums von pflanzenzellkulturen | |
| AR127097A1 (es) | Cepa de microalga que tiene el efecto de promover el crecimiento de las plantas y uso de la misma | |
| WO2002102971A3 (fr) | Methodes d'utilisation de cellules souches hematopoietiques cultivees afin d'induire une tolerance immunologique | |
| DK1797174T3 (da) | Fremgangsmåde til fremstilling af virusmateriale | |
| CN105062960A (zh) | 一种牙周膜干细胞原代分离及培养方法 |